Patients reported neuropsychiatric adverse events and associated factors among PLHIV patients receiving DTG-based regimen antiretroviral therapy real-life clinical practice in Ethiopia: multi center crossetional study
Being female, aged 47-75 years, unemployed, engaged in minimal or no physical activity, having a treatment duration of 6-24 months, advanced disease stage (WHO stage II-IV) and had a detectable viral load at the start of therapy. Monitoring these groups for neuropsychiatric adverse events is essential to facilitate timely interventions and improve patient outcomes.
Authors
- Eyayaw Ashete Belachew (ORCID: https://orcid.org/0000-0002-0421-4327)
- Gashaw Sisay Chanie (ORCID: https://orcid.org/0000-0001-9585-4196)
- Yibeltal Yismaw Gela (ORCID: https://orcid.org/0000-0002-1042-497X)
- Wondim Ayenew (ORCID: https://orcid.org/0000-0001-8504-8430)
- Mihret Melese (ORCID: https://orcid.org/0000-0002-5685-3585)
- Abdulwase Mohammed Seid
- Assefa Kebad Mengesha (ORCID: https://orcid.org/0000-0002-5998-0838)
- Melese Legesse Mitku
- Alemante Tafese Beyna (ORCID: https://orcid.org/0009-0003-9867-5443)
- Liknaw Workie Limenh (ORCID: https://orcid.org/0000-0002-9680-6134)
- Dereje Esubalew (ORCID: https://orcid.org/0000-0002-8968-4917)
- Wudneh Simegn
Institutions
- Ambo University (ET)
- University of Gondar (ET)
Publication Details
- Journal
- BMC Psychiatry
- Published
- 2025-04-16
- DOI
- https://doi.org/10.1186/s12888-025-06820-5
- Citations
- 4
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 5.58